Home›Companies›Biotech & Pharma›Revalesio

Revalesio Corp

Updated Oct 29, 2026·Latest SEC filing Dec 16, 2025·Suggest an edit

About Revalesio

Revalesio is a private company based in Tacoma, Washington. It has reported $103,398,607 raised in six offerings on Form D since June 2012.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 25, 2022Jun 9, 2022amended Dec 16, 2025$38,877,508of $40.3M target31$1.2MEquity, Debt, Options, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Jul 8, 2020Jul 22, 2020$20,371,187of $26.7M target22$925KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Jun 15, 2018Jun 27, 2018$6,000,000of $12.0M target6$1.0MEquity, Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Jun 23, 2016Jul 5, 2016$13,999,912fully sold11$1.2MEquityRule 506(b)Form D ↗
Apr 21, 2014May 5, 2014$13,500,000of $40.0M target3$4.5MEquity, OptionsRule 506(b)Form D ↗
Jun 6, 2012Jun 19, 2012$10,650,000of $20.0M target18$591KEquity, Options06Form D ↗
Total, six offerings$103,398,607

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Revalesio's Form D filed Dec 16, 2025.

JN
ER
Eric Russell
Director
GA
CF
JT
Jane Taylor
Director
MI
Matt Ireland
Director

Earlier filings also listed Liam Gallacher (director, last listed Jul 2020), Jeffrey Smith (director, last listed Jun 2018), Troy Alstead (director, last listed Jul 2016), Scott Walchek (director, last listed Jul 2016), Patrick Caruana (director, last listed Jul 2016), Marsha Russell (director, last listed Jul 2016), Lee Huntsman (director, last listed Jul 2016) and Bruce Buskirk (executive officer, last listed Jul 2016).

Sources

  1. SECRevalesio Corp Form D/A, filed Apr 12, 2024
  2. SECRevalesio Corp Form D, filed Jun 9, 2022
  3. SECRevalesio Corp filing history